CAL
OMIC

Capital Advisors Ltd’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Capital Advisors Ltd’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33
Closed – – 1666
2024
Q2 		$0 Buy
+33
New +$386 ﹤0.01% 1705
2022
Q4 		– Sell
-6
Closed – – 1736
2022
Q3 		$0 Buy
+6
New +$627 ﹤0.01% 1601

Other funds holding OMIC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Advisors Ltd's OMIC Position: Q3 2024 in Review

Capital Advisors Ltd sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2024, closing a stake of 33 shares.

Capital Advisors Ltd first reported a position in OMIC in Q3 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2024. 22 funds tracked by Wall St. Rank hold OMIC as of Q3 2024.

  • Capital Advisors Ltd reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 33 Singular Genomics Systems, Inc. Common Stock shares in Q3 2024.
  • Capital Advisors Ltd first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Capital Advisors Ltd's Singular Genomics Systems, Inc. Common Stock position peaked at $0 in Q2 2024.
  • 22 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2024.

Based on Capital Advisors Ltd's 13F filing for Q3 2024, filed 24 Oct 2024.